Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Number of trips per Whoosh user increased by 40%

8/8/24 WUSH

Yandex to issue 15.61 million shares for incentive program

8/8/24 YDEX

Board of Directors of Yandex recommended that dividends

8/8/24 YDEX

MD Medical opened a medical center in Anapa

8/8/24 MDMG

Rusagro began preparing for forced redomiciliation

8/8/24 AGRO

Rostelecom reorganized IT assets

8/8/24 RTKM

Fix Price in July opened its first store in the UAE

8/8/24 FIXP

Magnit closed a deal to buy 33% of Samberi

8/8/24 MGNT

Fix Price has reported for 6 months of 2024

8/8/24 FIXP

Fix Price's LFL sales increased by 1.9% in the 1st half of the year

8/8/24 FIXP